Unique ID issued by UMIN | UMIN000004777 |
---|---|
Receipt number | R000005688 |
Scientific Title | Study of the effect of nutrition management on gastrointestinal mucosa and absorption after esophagectomy in esophageal cancer patient |
Date of disclosure of the study information | 2011/04/01 |
Last modified on | 2014/12/24 22:19:42 |
Study of the effect of nutrition management on gastrointestinal mucosa and absorption after esophagectomy in esophageal cancer patient
Study of the effect of nutrition management after esophagectomy
Study of the effect of nutrition management on gastrointestinal mucosa and absorption after esophagectomy in esophageal cancer patient
Study of the effect of nutrition management after esophagectomy
Japan |
esophageal cancer
Gastrointestinal surgery |
Malignancy
NO
To evaluate the effect of total parenteral nutrition and enteral nutrition on gastrointestinal mucosa and absorption
Efficacy
Exploratory
Pragmatic
Phase II,III
Change ratio of diamin oxidase (DAO) activity on the day before operation and 3rd and 7th day after operation
Change of serum albumin, total protein and trace element concentration on the day before operation and 3rd and 7th day after operation
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
Numbered container method
2
Treatment
Medicine |
Total parental nutrition
enteral nutrition
20 | years-old | <= |
80 | years-old | > |
Male and Female
1) histlogically confirmed esophageal cancer
2) planning to undergo transthoracic esophagectomy and stomach reconstruction
3) WBC: 3000 /mm3>=, =<12000/mm3
and NE: >=1500 mm3
and PLT: >=100000 /mm3
and Hb: >=9.5 g/dL
and GOT, GPT: < 1.5 times of institutional upper limit
and T-Bil: =<1.5 g/dL
and ALP: < 2.5 times of institutional upper limit
and Cr: =<1.5 mg/dL
and Alb: >=2.8g/dL
4) Written informed concent
1) history of receiving gastrectomy
2) taking trace element
3) liver disease, mental disease, convulsive seizure, seizure disorder, heart disease, hemoglobinopathy, hemophilia, uncontrolled diabetes mellitus, autoimmune disease
4) history of severe adverse event due to ELNEOPA(R) or RACOL(R)
5) contraindication to ELNEOPA(R) or RACOL(R)
6) pregnancy
7) judged inadequate to this study by chief doctor
40
1st name | |
Middle name | |
Last name | Morihito Okada |
Hiroshima University Hospital
Surgical Oncology
1-2-3 kasumi, Minami-ku, Hiroshima
1st name | |
Middle name | |
Last name |
Hiroshima University Hospital
Surgical Oncology
1-2-3 kasumi, Minami-ku, Hiroshima
Surgical Oncology, Hiroshima University Hospital
Surgical Oncology, Hiroshima University Hospital
Self funding
NO
広島大学病院(広島県)
2011 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2010 | Year | 12 | Month | 20 | Day |
2011 | Year | 02 | Month | 01 | Day |
2014 | Year | 11 | Month | 30 | Day |
2014 | Year | 11 | Month | 30 | Day |
2014 | Year | 12 | Month | 24 | Day |
2014 | Year | 12 | Month | 24 | Day |
2010 | Year | 12 | Month | 22 | Day |
2014 | Year | 12 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005688
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |